Over the past 12 months, 0 insiders at Avid Bioservices, Inc. filed 0 open-market SEC Form 4 transactions on CDMO: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 10, 25 | Richard A. RichieriChief Operations Officer | SELL | 2.3K | $12.37 | $28K |
| Dec 26, 24 | Nicholas Stewart GreenPresident & CEO | SELL | 88.2K | $12.22 | $1.1M |
| Dec 26, 24 | Daniel R HartChief Financial Officer | SELL | 20.8K | $12.22 | $255K |
| Dec 26, 24 | Matthew R. KwietniakChief Commercial Officer | SELL | 10.2K | $12.22 | $124K |
| Dec 26, 24 | Richard A. RichieriChief Operations Officer | SELL | 3.8K | $12.22 | $47K |
| Dec 24, 24 | Nicholas Stewart GreenPresident & CEO | SELL | 51.7K | $12.27 | $634K |
| Dec 23, 24 | Nicholas Stewart GreenPresident & CEO | SELL | 100.0K | $12.28 | $1.2M |
| Dec 20, 24 | Nicholas Stewart GreenPresident & CEO | SELL | 75.0K | $12.31 | $923K |
| Oct 14, 24 | Matthew R. KwietniakChief Commercial Officer | SELL | 119 | $10.15 | $1K |
| Oct 10, 24 | Nicholas Stewart GreenPresident & CEO | SELL | 17.2K | $10.05 | $173K |
| Oct 10, 24 | Matthew R. KwietniakChief Commercial Officer | SELL | 982 | $10.05 | $10K |
| Oct 10, 24 | Richard A. RichieriChief Operations Officer | SELL | 2.0K | $10.05 | $20K |
| Jul 15, 24 | Matthew R. KwietniakChief Commercial Officer | SELL | 307 | $8.36 | $3K |
| Jul 15, 24 | Richard A. RichieriChief Operations Officer | SELL | 530 | $8.36 | $4K |
| Jul 12, 24 | Matthew R. KwietniakChief Commercial Officer | SELL | 119 | $8.05 | $958 |
| Jul 11, 24 | Richard A. RichieriChief Operations Officer | SELL | 1.5K | $7.54 | $11K |
| Jul 10, 24 | Nicholas Stewart GreenPresident & CEO | SELL | 7.7K | $7.54 | $58K |
| Jul 10, 24 | Matthew R. KwietniakChief Commercial Officer | SELL | 444 | $7.54 | $3K |
| Jul 10, 24 | Richard A. RichieriChief Operations Officer | SELL | 910 | $7.54 | $7K |
| Apr 30, 24 | Nicholas Stewart GreenPresident & CEO | SELL | 11.8K | $7.40 | $87K |
| Apr 30, 24 | Daniel R HartChief Financial Officer | SELL | 2.8K | $7.40 | $21K |
| Apr 30, 24 | Matthew R. KwietniakChief Commercial Officer | SELL | 1.2K | $7.40 | $9K |
| Apr 30, 24 | Richard A. RichieriChief Operations Officer | SELL | 1.0K | $7.40 | $7K |
| Apr 30, 24 | Mark R ZiebellV. P., General Counsel | SELL | 1.6K | $7.40 | $12K |
| Jan 12, 24 | Matthew R. KwietniakChief Commercial Officer | SELL | 274 | $6.77 | $2K |
| Jan 10, 24 | Daniel R HartChief Financial Officer | SELL | 2.4K | $6.17 | $15K |
| Jan 10, 24 | Matthew R. KwietniakChief Commercial Officer | SELL | 1.1K | $6.17 | $7K |
| Jan 10, 24 | Richard A. RichieriChief Operations Officer | SELL | 1.1K | $6.17 | $7K |
| Jan 10, 24 | Mark R ZiebellV. P., General Counsel | SELL | 1.3K | $6.17 | $8K |
| Dec 15, 23 | Richard B HancockDirector | BUY | 23.0K | $5.86 | $135K |
| Dec 13, 23 | Richard B HancockDirector | BUY | 38.8K | $5.21 | $202K |
| Oct 12, 23 | Matthew R. KwietniakChief Commercial Officer | SELL | 255 | $9.19 | $2K |
| Oct 10, 23 | Daniel R HartChief Financial Officer | SELL | 2.0K | $9.20 | $19K |
| Oct 10, 23 | Matthew R. KwietniakChief Commercial Officer | SELL | 970 | $9.20 | $9K |
| Oct 10, 23 | Richard A. RichieriChief Operations Officer | SELL | 894 | $9.20 | $8K |
| Oct 10, 23 | Mark R ZiebellV. P., General Counsel | SELL | 1.1K | $9.20 | $10K |
| Sep 21, 23 | Joseph CarleoneDirector | BUY | 20.0K | $9.53 | $191K |
| Jul 31, 23 | Nicholas Stewart GreenPresident & CEO | SELL | 19.5K | $12.99 | $254K |
| Jul 13, 23 | Richard A. RichieriChief Operations Officer | SELL | 2.7K | $13.40 | $37K |
| Jul 12, 23 | Matthew R. KwietniakChief Commercial Officer | SELL | 252 | $13.61 | $3K |
| Jul 11, 23 | Daniel R HartChief Financial Officer | SELL | 3.8K | $13.86 | $52K |
| Jul 11, 23 | Richard A. RichieriChief Operations Officer | SELL | 1.4K | $13.86 | $20K |
| Jul 11, 23 | Mark R ZiebellV. P., General Counsel | SELL | 5.0K | $13.86 | $70K |
| Jul 10, 23 | Nicholas Stewart GreenPresident & CEO | SELL | 7.5K | $13.77 | $104K |
| Jul 10, 23 | Daniel R HartChief Financial Officer | SELL | 1.3K | $13.77 | $17K |
| Jul 10, 23 | Matthew R. KwietniakChief Commercial Officer | SELL | 477 | $13.77 | $7K |
| Jul 10, 23 | Richard A. RichieriChief Operations Officer | SELL | 510 | $13.77 | $7K |
| Jul 10, 23 | Mark R ZiebellV. P., General Counsel | SELL | 687 | $13.77 | $9K |
| Jun 30, 23 | Mark R ZiebellV. P., General Counsel | SELL | 1.3K | $13.49 | $17K |
| Jun 29, 23 | Nicholas Stewart GreenPresident & CEO | SELL | 40.9K | $12.70 | $519K |
Over the past 12 months, insiders at Avid Bioservices, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on CDMO, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market CDMO insider purchase in our data was $202K by Richard B Hancock, Director, filed on Dec 13, 23.
0 different insiders at Avid Bioservices, Inc. filed open-market SEC Form 4 transactions on CDMO over the last 12 months.
InsiderTape plots every CDMO insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Avid Bioservices, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →